Sven Påhlman (Former)
11 – 20 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Hypoxia and Cancer Stem Cell Regulation
2017) p.101-126(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Hypoxia, pseudohypoxia and cellular differentiation
(
- Contribution to journal › Article
-
Mark
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
(
- Contribution to journal › Article
-
Mark
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
(
- Contribution to journal › Article
-
Mark
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(51). p.10856-10858(
- Contribution to journal › Letter
- 2016
-
Mark
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells.
(
- Contribution to journal › Article
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
(
- Contribution to journal › Article
-
Mark
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
(
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
(
- Contribution to journal › Article